glp-1 inflammation The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury The Therapeutic Potential of GLP-1

For obese populations with comorbidities such as type 2 diabetes, heart failure, and obstructive sleep apnea, it holds extensive therapeutic value

Hormones (Athens) (2018) 17:18396

For example, semaglutide (injectable) and tirzepatide (injectable) have shown larger mean weight loss in trials

10.1016/j.ctim.2020.102609 201 YuB

The American Diabetes Association Standards of Care do not include berberine in evidence-based treatment algorithms, and patients with type 2 diabetes should not discontinue prescribed medications in favor of supplements without medical supervision

A 2026 UK review of the neuroinflammation / white-matter / small-fibre mechanism, the 2025 BSR guideline, the BDNF / HGF/c-Met case, the elevated lymphoma risk vs pro-proliferative c-Met and why specialist care, not a peptide, comes first Read the full review Microbiome & Gut-Brain Neuroscience 16 June 2026 Dihexa for Gut-Brain Axis Brain Fog: IBS, SIBO, Leaky Gut, the Microbiome & the 2026 UK Review My guts a mess and so is my head are they connected? Increasingly, the science says they can be